(Q42610631)

3 November 2017

title

Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers (English)

1 reference

3 November 2017

Linda R Peterson

1

1 reference

ORCID Public Data File 2021

author name string

Kenneth B Schechtman

2

1 reference

3 November 2017

Gregory A Ewald

3

1 reference

3 November 2017

Edward M Geltman

4

1 reference

3 November 2017

Lisa de las Fuentes

5

1 reference

3 November 2017

Timothy Meyer

6

1 reference

3 November 2017

Pamela Krekeler

7

1 reference

3 November 2017

Martha L Moore

8

1 reference

3 November 2017

Joseph G Rogers

9

1 reference

3 November 2017

language of work or name

1 reference

1 October 2003

1 reference

The Journal of Heart and Lung Transplantation

3 November 2017

published in

1 reference

3 November 2017

volume

22

1 reference

3 November 2017

issue

10

1 reference

3 November 2017

page(s)

1141-1148

1 reference

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Effects of gender, age, and fitness level on response of VO2max to training in 60-71 yr olds

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Burden of myocardial damage in cardiac allograft rejection: Scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Chronic cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Mechanism of cyclosporine-induced hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

24th Bethesda conference: Cardiac transplantation. Task Force 5: Complications.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Production of severe atheroma in a transplanted human heart.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Peak VO(2): a simple yet enduring standard

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Prognosis in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Survival after the onset of congestive heart failure in Framingham Heart Study subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

Relation between gender, etiology and survival in patients with symptomatic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2802%2901225-1

7 January 2021

10.1016/S1053-2498(02)01225-1

Identifiers

DOI

1 reference

3 November 2017

1 reference